N-Hydroxycytidine(CAS: 3258-02-4)

N-Hydroxycytidine (CAS: 3258-02-4) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements for chemical substances. It is classified as a Hazardous Substance and requires proper labeling, storage, and handling to comply with these regulations.

There are several alternatives to N-Hydroxycytidine in synthesis, including 5-Azacytidine and 2-Aminopurine. These analogs can be used as substitutes depending on the specific requirements of the synthesis process. Common alternative reagents include cytosine and its derivatives, which may offer similar functionalities in different synthetic contexts.

The market for N-Hydroxycytidine (CAS: 3258-02-4) is growing due to its applications in antiviral and anticancer research. Recent trends show increased interest in its potential as an antiviral agent against RNA viruses. Research is also focusing on its use in gene editing and as a potential anticancer drug. Pricing trends indicate steady demand with moderate price stability.

Waste containing N-Hydroxycytidine (CAS: 3258-02-4) should be collected and disposed of in accordance with local hazardous waste regulations. Proper incineration or professional waste disposal services are recommended to ensure environmental safety. Care should be taken to prevent contamination and ensure all safety precautions are followed during handling and disposal to avoid health risks and environmental damage.